Vaginal atrophy
Genitourinary syndrome of menopause (GSM). Thinning, dryness, burning, painful intercourse. Treatable with combined hormonal and energy device protocols.
A 60–90 minute new-patient consult with Dr. Berman. We listen, we work it up, we make a plan together.
Atrophy. Dryness. Postpartum laxity. Discomfort during intimacy. Energy-based, regenerative, and hormonal options — used in combination, matched to physiology, monitored over time.
Genitourinary syndrome of menopause (GSM). Thinning, dryness, burning, painful intercourse. Treatable with combined hormonal and energy device protocols.
Postpartum, perimenopause, post-cancer treatment, or contraception-related. Topical estradiol, DHEA, MonaLisa Touch, and PRP options.
Tissue stretching, sensation changes, structural shifts after vaginal delivery. CO2 laser and PRP can restore tone and sensitivity.
Tissue-driven dyspareunia from atrophy, scarring, or atrophic vaginitis. MonaLisa Touch + topical hormonal therapy is first-line in most cases.
Chronic UTIs, BV, yeast — often downstream of GSM. Treating the underlying tissue prevents the recurrence cycle.
Reduced genital sensation, arousal difficulty, post-treatment changes. PRP and exosome protocols target the underlying neurovascular tissue.
Detailed reproductive, hormonal, surgical, and sexual history. Discussion of priorities and outcome targets.
Pelvic exam, tissue assessment, hormonal evaluation. Vaginal pH and mucosal scoring where appropriate.
MonaLisa Touch course (typical 3 sessions, 4–6 weeks apart), PRP/PRF, exosomes, topical hormonal optimization — combined as warranted.
Annual MonaLisa Touch maintenance, ongoing topical hormonal therapy, periodic PRP boost. Long-term tissue health is the goal.
Detailed health intake + symptom severity scoring submitted online before the first appointment.
60–90 min in-person. Pelvic exam, treatment plan, scheduling for first MonaLisa Touch session.
MonaLisa Touch: 3 sessions, 4–6 weeks apart. Brief, in-office, topical anesthetic. Most patients return to normal activity same day.
Symptom score retake. Tissue assessment. Topical regimen adjusted as needed.
Full symptom reassessment. Most patients report substantial improvement in dryness, comfort, and sensation. Maintenance plan written.

No. The procedure uses topical anesthetic; most patients describe it as a brief, mild internal vibration. The session itself is under 10 minutes. There is no recovery time — patients typically return to normal activity that day.
MonaLisa Touch CO2 laser is a non-hormonal option and is well-suited to patients who cannot use systemic estradiol. We work closely with your oncology team to confirm appropriateness and coordinate care.
The practice operates out-of-network. We provide superbills you can submit to your insurance for partial reimbursement under your out-of-network benefits. We accept HSA/FSA cards.
Every initial consultation is conducted by Dr. Berman. Follow-ups may be conducted by Dr. Berman or a member of the clinical team based on the visit type, but Dr. Berman remains the supervising physician for every patient on the panel.
Results from a 3-session MonaLisa Touch course typically hold for 12–18 months, with annual maintenance. PRP and exosome benefits typically last 9–12 months. Combined with topical hormonal therapy, the outcome is durable.